Helicobacter pylori infection and gastric cancer: Host, bug, environment, or all three?

Current Gastroenterology Reports

Volumn 6, Issue 6, 2004, Pages 429-435

  Menaker, Rena J ^a   Sharaf, Amy A ^a   Jones, Nicola L ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADHESIN; BLOOD ANTIGEN BINDING ADHESIN; CAGA PROTEIN; CYCLIN D1; CYCLOOXYGENASE 2; GAMMA INTERFERON; GLYCOPROTEIN GP 130; GLYCOPROTEIN P; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MULTIDRUG RESISTANCE PROTEIN 1; MYC PROTEIN; PHOSPHOLIPASE C; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; SCATTER FACTOR; STAT3 PROTEIN; SURVIVIN; SYNAPTOTAGMIN; TREFOIL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACUOLATING TOXIN;

APOPTOSIS; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CANCER INCIDENCE; CANCER RISK; CARCINOGENICITY; COLORECTAL CANCER; ENVIRONMENTAL FACTOR; ENZYME INHIBITION; FOOD INTAKE; GASTRITIS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GEOGRAPHY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENICITY ISLAND; PREVALENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK FACTOR; SALT INTAKE; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

EID: 9944226682     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-004-0063-9     Document Type: Review

References (56)

1. Peek RM Jr, Blaser MJ: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002, 2:28-37.
2. Sipponen P, Marshall BJ: Gastritis and gastric cancer: Western countries. Gastroenterol Clin North Am 2000, 29: 79-592.
3. Backert S, Schwarz T, Miehlke S, et al.: Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer. Infect Immun 2004, 72:1043-1056.
4. Kikuchi S, Crabtree JE, Forman D, et al.: Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults. Am J Gastroenterol 1999, 94:3455-3459.
5. Suerbaum S, Michetti P: Helicobacter pylori infection. N Engl J Med 2002, 347:1175-1186.
6. Selbach M, Moese S, Hauck CR, et al.: Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 2002, 277:6775-6778.
7. Stein M, Rappuoli R, Covacci A: Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A 2000, 97: 263-1268.
8. Lai YP, Yang JC, Lin TZ, et al.: CagA tyrosine phosphorylation in gastric epithelial cells caused by Helicobacter pylori in patients with gastric adenocarcinoma. Helicobacter 2003, 8:235-243.
9. Jeffers M, Rong S, Anver M, et al.: Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. Oncogene 1996, 13:853-856.
10. Churin Y, Al-Ghoul L, Kepp O, et al.: Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 2003, 161:249-255.
11. Higashi H, Tsutsumi R, Muto S, et al.: SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002, 295:683-686.
12. Azuma T, Yamazaki S, Yamakawa A, et al.: Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis 2004, 189:820-827.
13. Karin M, Cao Y, Greten FR, et al.: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002, 2:301-310.
14. Bowie A, O'Neill LA: Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000, 59:13-23.
15. Yang GF, Deng CS, Xiong YY, et al.: Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection. World J Gastroenterol 2004, 10:491-496.
16. Cover TL: The vacuolating cytotoxin of Helicobacter pylori Mol Microbiol 1996 20:241-246.
17. Miehlke S, Kirsch C, Agha-Amiri K, et al.: The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 2000, 87: 22-327.
18. Lehours P, Menard A, Dupouy S, et al.: Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma. Infect Immun 2004, 72:880-888.
19. Ilver D, Arnqvist A, Ogren J, et al.: Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998, 279:373-377.
20. Prinz C, Schoniger M, Rad R, et al.: Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 2001, 61:1903-1909.
21. Zambon CF, Navaglia F, Basso D, et al.: Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol 2003, 56:287-291.
22. Macarthur M, Hold GL, El-Omar EM: Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 2004, 286:G515-G520.
23. Danese S, Cremonini F, Armuzzi A, et al.: Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa. Scand J Gastroenterol 2001, 36: 47-250.
24. Smoot DT, Elliott TB, Verspaget HW, et al.: Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis 2000, 21:2091-2095.
25. Jaiswal M, LaRusso NF, Gores GJ: Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 2001, 281:G626-G634.
26. Rieder G, Hofmann JA, Hatz RA, et al.: Up-regulation of inducible nitric oxide synthase in Helicobacter pylori associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type. Int J Med Microbiol 2003, 293:403-412.
27. van Rees BP, Saukkonen K, Ristimaki A, et al.: Cyclooxygenase-2 expression during carcinogenesis in the human stomach J Pathol 2002, 196:171-179.
28. Williams CS, Smalley W, DuBois RN: Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 1997, 100:1325-1329.
29. Guo XL, Wang LE, Du SY, et al.: Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer. World J Gastroenterol 2003, 9:246-249.
30. Nardone G, Rocco A, Vaira D, et al.: Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H. pylori-related gastric carcinogenesis. J Pathol 2004, 202: 05-312.
31. Reymann A, Woermann C, Froschle G, et al.: Sensitive assessment of cytostatic drug resistance-mediating factors MDR1 and MRP in tumors of the gastrointestinal tract by RT-PCR. Int J Clin Pharmacol Ther 1998, 36:55-57.
32. Patel VA, Dunn MJ, Sorokin A: Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J Biol Chem 2002, 277: 8915-38920.
33. Yu H, Jove R: The STATs of cancer: new molecular targets come of age. Nat Rev Cancer 2004, 4:97-105.
34. Mora LB, Buettner R, Seigne J, et al.: Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells Cancer Res 2002, 62:6659-6666.
35. Kanda N, Seno H, Konda Y, et al.: STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004, 23:4921-4929.
36. Altieri DC: Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003, 3:46-54.
37. Kawasaki H, Altieri DC, Lu CD, et al.: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998, 58:5071-5074.
38. Tebbutt NC, Giraud AS, Inglese M, et al.: Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 2002, 8:1089-97.
39. Judd LM, Alderman BM, Howlett M, et al.: Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 2004, 126: 96-207.
40. El-Omar EM, Rabkin CS, Gammon MD, et al.: Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003, 124:1193-1201.
41. El-Omar EM, Carrington M, Chow WH, et al.: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
42. Takashima M, Furuta T, Hanai H, et al.: Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001, 48:765-773.
43. Rad R, Prinz C, Neu B, et al.: Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003, 188:272-281.
44. Wijnhoven BP, Dinjens WN, Pignatelli M: E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000, 87:992-1005.
45. Guilford P, Hopkins J, Harraway J, et al.: E-cadherin germline mutations in familial gastric cancer. Nature 1998, 392:402-405.
46. Becker KF, Atkinson MJ, Reich U, et al.: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994, 54:3845-3852.
47. Kang GH, Shim YH, Jung HY, et al.: CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001, 61:2847-2851.
48. Chan AO, Lam SK, Wong BC, et al.: Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003, 52:502-506.
49. Moss SF, Sordillo EM, Abdalla AM, et al.: Increased gastric epithelial cell apoptosis associated with colonization with cagA+ Helicobacter pylori strains. Cancer Res 2001, 61: 406-1411.
50. Galmiche A, Rassow J, Doye A, et al.: The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J 2000, 19:6361-6370.
51. Fan X, Gunasena H, Cheng Z, et al.: Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J Immunol 2000, 165:1918-1924.
52. Shibayama K, Doi Y, Shibata N, et al.: Apoptotic signaling pathway activated by Helicobacter pylori infection and increase of apoptosis-inducing activity under serum-starved conditions. Infect Immun 2001, 69:3181-3189.
53. Zhang H, Fang DC, Wang RQ, et al.: Effect of Helicobacter pylori infection on expression of Bcl-2 family members in gastric adenocarcinoma. World J Gastroenterol 2004, 10: 27-230.
54. Fox JC, Dangler CA, Taylor NS, et al.: High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res 1999, 59:4823-4828.
55. Fox IG, Rogers AB, Ihrig M, et al.: Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 2003, 63:942-950.
56. Tari A, Kodama K, Sumii M, et al.: Does intragastric nitrite concentration reflect gastric carcinogenesis in Japanese Helicobacter pylori-infected patients? Dig Dis Sci 2003, 48: 730-1736.